| human | Q5 |
| P496 | ORCID iD | 0000-0002-5665-5212 |
| 0000-0003-0240-5127 | ||
| P1153 | Scopus author ID | 7101624045 |
| P69 | educated at | Aarhus University | Q924265 |
| P108 | employer | Aarhus University | Q924265 |
| P734 | family name | Johansen | Q21452143 |
| Johansen | Q21452143 | ||
| Johansen | Q21452143 | ||
| P106 | occupation | researcher | Q1650915 |
| Q38336576 | 1alpha,25(OH)(2)D(3) regulates NF-kappaB DNA binding activity in cultured normal human keratinocytes through an increase in IkappaBalpha expression. |
| Q73873222 | 1alpha,25-dihydroxyvitamin D3 induced differentiation of cultured human keratinocytes is accompanied by a PKC-independent regulation of AP-1 DNA binding activity |
| Q44369492 | 1alpha,25-dihydroxyvitamin D3 stimulates activator protein 1 DNA-binding activity by a phosphatidylinositol 3-kinase/Ras/MEK/extracellular signal regulated kinase 1/2 and c-Jun N-terminal kinase 1-dependent increase in c-Fos, Fra1, and c-Jun express |
| Q42468308 | A Characterization of the expression of 14-3-3 isoforms in psoriasis, basal cell carcinoma, atopic dermatitis and contact dermatitis |
| Q45065352 | Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin. |
| Q54649143 | Adalimumab therapy rapidly inhibits p38 mitogen-activated protein kinase activity in lesional psoriatic skin preceding clinical improvement. |
| Q54200281 | Aldara®-induced skin inflammation: studies of patients with psoriasis. |
| Q35045606 | Anti-inflammatory effect of a retrovirus-derived immunosuppressive peptide in mouse models |
| Q92090102 | Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma |
| Q46116498 | CCL27 expression is regulated by both p38 MAPK and IKKβ signalling pathways. |
| Q83060208 | Caspase-5 expression is upregulated in lesional psoriatic skin |
| Q86693188 | Changes in mRNA expression precede changes in microRNA expression in lesional psoriatic skin during treatment with adalimumab |
| Q53114406 | Characterization of TNF-α- and IL-17A-Mediated Synergistic Induction of DEFB4 Gene Expression in Human Keratinocytes through IκBζ. |
| Q28301222 | Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin |
| Q53923175 | Comment on 'Tumour necrosis factor-α plays a significant role in the Aldara-induced skin inflammation in mice': reply from authors. |
| Q28547394 | Comparative Analysis of Two Gene-Targeting Approaches Challenges the Tumor-Suppressive Role of the Protein Kinase MK5/PRAK |
| Q90674813 | Differential Effects of Digoxin on Imiquimod-Induced Psoriasis-Like Skin Inflammation on the Ear and Back |
| Q54611162 | Dimethylfumarate inhibits MIF-induced proliferation of keratinocytes by inhibiting MSK1 and RSK1 activation and by inducing nuclear p-c-Jun (S63) and p-p53 (S15) expression. |
| Q34627517 | Dimethylfumarate specifically inhibits the mitogen and stress-activated kinases 1 and 2 (MSK1/2): possible role for its anti-psoriatic effect. |
| Q88150144 | Efficacy of ustekinumab in palmoplantar pustulosis and palmoplantar pustular psoriasis |
| Q57244267 | Expression and Localization of Peroxisome Proliferator-Activated Receptors and Nuclear Factor κB in Normal and Lesional Psoriatic Skin |
| Q49498294 | Generation and Culturing of Primary Human Keratinocytes from Adult Skin. |
| Q51542359 | IL-17F regulates psoriasis-associated genes through IκBζ. |
| Q79668293 | IL-20 gene expression is induced by IL-1beta through mitogen-activated protein kinase and NF-kappaB-dependent mechanisms |
| Q43408700 | IL-20, IL-21 and p40: potential biomarkers of treatment response for ustekinumab. |
| Q39964041 | IL-8 and p53 are inversely regulated through JNK, p38 and NF-kappaB p65 in HepG2 cells during an inflammatory response. |
| Q37322440 | Inflammasomes and inflammatory caspases in skin inflammation |
| Q52623283 | Inflammation-induced alterations in the skin barrier function: implications in atopic dermatitis. |
| Q54380285 | Inflammatory cytokines break down intrinsic immunological tolerance of human primary keratinocytes to cytosolic DNA. |
| Q87442063 | Interleukin 20 protein locates to distinct mononuclear cells in psoriatic skin |
| Q41946482 | Interleukin 20 regulates dendritic cell migration and expression of co-stimulatory molecules. |
| Q40823087 | Interleukin-23 in early disease development in rheumatoid arthritis. |
| Q46545785 | Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin. |
| Q92447126 | Investigating the Role of I Kappa B Kinase ε in the Pathogenesis of Psoriasis |
| Q36238508 | IκBζ is a key driver in the development of psoriasis |
| Q38937698 | IκBζ: A key protein in the pathogenesis of psoriasis |
| Q84452894 | Kinetics and differential expression of the skin-related chemokines CCL27 and CCL17 in psoriasis, atopic dermatitis and allergic contact dermatitis |
| Q48327302 | Langerhans cell markers CD1a and CD207 are the most rapidly responding genes in lesional psoriatic skin following adalimumab treatment. |
| Q38291462 | Leptin deficiency in mice counteracts imiquimod (IMQ)-induced psoriasis-like skin inflammation while leptin stimulation induces inflammation in human keratinocytes. |
| Q81674277 | Lysophosphatidylcholine induces keratinocyte differentiation and upregulation of AP-1- and NF-kappaB DNA-binding activity |
| Q39941132 | MK2 regulates the early stages of skin tumor promotion. |
| Q42046007 | Measuring serum concentrations of interleukin-33 in atopic dermatitis is associated with potential false positive results. |
| Q44433774 | Mice lacking MSK1 and MSK2 show reduced skin tumor development in a two-stage chemical carcinogenesis model. |
| Q39437081 | MicroRNA normalization candidates for quantitative reverse-transcriptase polymerase chain reaction in real time in lesional and nonlesional psoriatic skin. |
| Q96580309 | MicroRNA-106b Regulates Expression of the Tumour Suppressors p21 and TXNIP and Promotes Tumour Cell Proliferation in Mycosis Fungoides |
| Q80147884 | Mitogen- and stress-activated protein kinase 2 and cyclic AMP response element binding protein are activated in lesional psoriatic epidermis |
| Q92371819 | Non-random Plaque-site Recurrence of Psoriasis in Patients Treated with Dead Sea Climatotherapy |
| Q36231590 | Pathway Analysis of Skin from Psoriasis Patients after Adalimumab Treatment Reveals New Early Events in the Anti-Inflammatory Mechanism of Anti-TNF-α |
| Q54411085 | Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFα therapy. |
| Q46849090 | Pro-inflammatory cytokine release in keratinocytes is mediated through the MAPK signal-integrating kinases. |
| Q50059167 | Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study |
| Q42489636 | Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2. |
| Q47106368 | Protein phosphatase 2Cδ/Wip1 regulates phospho-p90RSK2 activity in lesional psoriatic skin. |
| Q46261780 | Reduced oxazolone-induced skin inflammation in MAPKAP kinase 2 knockout mice. |
| Q43861402 | Role of p38 mitogen-activated protein kinase isoforms in murine skin inflammation induced by 12-O-tetradecanoylphorbol 13-acetate. |
| Q36363330 | STAT2 is involved in the pathogenesis of psoriasis by promoting CXCL11 and CCL5 production by keratinocytes |
| Q51044806 | Studies of Jak/STAT3 expression and signalling in psoriasis identifies STAT3-Ser727 phosphorylation as a modulator of transcriptional activity. |
| Q54704060 | TARC augments TNF-alpha-induced CTACK production in keratinocytes. |
| Q44044237 | TNFα- and IL-17A-mediated S100A8 expression is regulated by p38 MAPK. |
| Q51272730 | TRIM21 is important in the early phase of inflammation in the imiquimod-induced psoriasis-like skin inflammation mouse model. |
| Q89384221 | TSLP, IL-31, IL-33 and sST2 are new biomarkers in endophenotypic profiling of adult and childhood atopic dermatitis |
| Q51314349 | The "Alarmins" HMBG1 and IL-33 Downregulate Structural Skin Barrier Proteins and Impair Epidermal Growth. |
| Q92895735 | The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary Syndrome |
| Q80540798 | The activity of caspase-1 is increased in lesional psoriatic epidermis |
| Q37326495 | The caspase-cleaved form of LYN mediates a psoriasis-like inflammatory syndrome in mice. |
| Q43296378 | The expression and phosphorylation of eukaryotic initiation factor 4E are increased in lesional psoriatic skin. |
| Q54295087 | The expression of dual-specificity phosphatase 1 mRNA is downregulated in lesional psoriatic skin. |
| Q89230350 | The human IL-17A/F heterodimer regulates psoriasis-associated genes through IκBζ |
| Q46438489 | The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling |
| Q81288767 | The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin |
| Q33523814 | The p38 MAPK regulates IL-24 expression by stabilization of the 3' UTR of IL-24 mRNA. |
| Q48165501 | The role of leptin in psoriasis comprises a proinflammatory response by the dermal fibroblast |
| Q54626083 | The role of mitogen- and stress-activated protein kinase 1 and 2 in chronic skin inflammation in mice. |
| Q38334718 | Tumor necrosis factor α-mediated induction of interleukin 17C in human keratinocytes is controlled by nuclear factor κB. |
| Q38333148 | Tumor necrosis factor-alpha-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappaB. |
| Q38937859 | Tumour necrosis factor-α plays a significant role in the Aldara-induced skin inflammation in mice. |
| Q87412078 | Ustekinumab in the treatment of refractory chronic cutaneous lupus erythematosus: a case report |
Search more.